Ubtech Robotics Grapples with Battery Backlash and Share Overhang as Unitree’s Market Debut Looms
Published on 07/12/2026 at 17:16 | Redaktion boerse-global.de
The 990,000-yuan price tag on Ubtech Robotics’ U1 Ultra humanoid robot was already enough to raise eyebrows. But revelations that the machine’s battery lasts just two to four hours have added fresh fuel to investor skepticism, prompting the company to issue an unusual public defence on July 12. The timing could hardly be worse: just three days earlier, Hong Kong’s exchange cleared 5.45 million H-shares for trading under Ubtech’s “Full Circulation” programme, potentially flooding the market with a new tranche of liquid stock at a moment of maximum vulnerability.
Shares closed at €9.60 on Friday, down 2.86% on the day and 18.64% for the week. The stock now sits barely 2.12% above its 52-week low of €9.40, touched on July 10. The battery controversy, which Ubtech dismissed as “current industry standard” for humanoid robots, has intensified scrutiny of a company already fighting a 33.79% year-to-date decline.
The share unlock complicates the technical picture
The newly tradable shares stem from a programme that converts previously non-tradable domestic A-shares into exchange-listed H-shares. Bullish analysts argue the move is necessary to attract large institutional investors that require deeper daily liquidity. With a 14-day relative strength index of 38.0, the stock is approaching oversold territory, raising hopes of a technical bounce toward the 50-day moving average of €11.82 – provided the market can absorb the overhang.
But the bear camp sees the unlock as a potential catalyst for further selling, especially after the stock’s 30-day slide of 20.04%. Existing domestic shareholders, sitting on losses, may choose to exit now that their holdings are tradable. The 52-week high of €17.00 is now 43.53% above the current price, a gap that suggests the market has sharply re-rated Ubtech’s growth prospects. With annualised 30-day volatility of 85.04%, risk remains elevated, and no clear technical floor exists below the €9.40 support level.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
Unitree presses its advantage
While Ubtech scrambles to defend its flagship product, rival Unitree Technology is closing in on its own initial public offering. The Shanghai STAR Market IPO passed regulatory review on June 1, and the status was updated to “submitted for registration” the following day. Unitree aims to raise 4.202 billion yuan at a valuation of roughly 42 billion yuan (€4.78 billion) – a figure that matches Ubtech’s current market capitalisation.
Unitree’s momentum is backed by hard numbers. The company delivered more than 5,500 humanoid robots in 2025, claiming a 32.4% global market share. Its investor roster, which includes Meituan, Tencent, and Alibaba, adds further credibility. The prospect of a deep-pocketed competitor going public just as Ubtech’s own product faces battery criticism raises the spectre of a sustained capital rotation out of Ubtech and into Unitree.
What comes next
The €9.40 level is the line in the sand. If it holds, a consolidation phase is likely while the market digests the new floating shares. If it breaks, stop-loss orders could accelerate the decline. The next concrete catalyst will be Unitree’s actual trading debut on the STAR Market; only then will it become clear whether capital is indeed flowing permanently to the rival.
Ubtech Robotics at a turning point? This analysis reveals what investors need to know now.
Ubtech has responded by expanding its research and development budget, partly to counter advances from competitors such as Tesla’s Optimus Gen-3. But for now, the company remains caught between a product perception problem and a structural increase in share supply, with a fast-approaching competitor poised to test investor loyalty.
Ad
Ubtech Robotics Stock: New Analysis - 12 July
Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
